MedPath

The Effect of Dexmedetomidine Preconditioning for Myocardial Protection after Cardiopulmonary Bypass in the Elderly

Phase 4
Conditions
Dexmedetomidine Preconditioning Cardiac suregeryMyocardial Protection after Cardiopulmonary BypassElderly
Dexmedetomidine Preconditioning
Cardiac suregery
Myocardial Protection after Cardiopulmonary Bypass
Elderly
Registration Number
TCTR20200417004
Lead Sponsor
Ratchadapiseksompotch Fund, Faculty of Medicine, Chulalongkorn University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending (Not yet recruiting)
Sex
All
Target Recruitment
40
Inclusion Criteria

age at least 65 years old
undergoing cardiac surgery with CPB

Exclusion Criteria

chronic kidney disease GFR < 15 ml/min/1.73m2
Allergic to certain drug use in the research : dexmedetomidine, sevoflurane, propofol, etomidate และ fentanyl

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Cardiac troponin I at 24 hours after release of aortic cross clamp Cardiac troponin I from blood with ABBOT alinity I series
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath